During the past decade, Tyler Research Institute, LLC conducted 32 clinical trials. In the 10-year time frame, 32 clinical trials started and 11 clinical trials were completed, i.e. on average, 34.4% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 11 clinical trials were completed. i.e. 61.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Tyler Research Institute, LLC" #1 sponsor was "Pfizer" with 5 trials, followed by "Bristol-Myers Squibb" with 4 trials sponsored, "Hoffmann-La Roche" with 4 trials sponsored, "Janssen Research & Development, LLC" with 4 trials sponsored and "Takeda" with 4 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tyler Research Institute, LLC" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 3 trials as a collaborator and "Gilead Sciences" with 2 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Tyler Research Institute, LLC" are "Ulcerative Colitis" (13 trials), "Crohn's Disease" (8 trials), "Colitis, Ulcerative" (5 trials), "Crohn Disease" (5 trials) and "Eosinophilic Esophagitis" (2 trials). Many other conditions were trialed in "Tyler Research Institute, LLC" in a lesser frequency.

Most popular intervention types in "Tyler Research Institute, LLC" are "Drug" (32 trials), "Other" (6 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (16 trials), "Etrasimod" (5 trials), "Guselkumab" (4 trials), "Etrolizumab" (3 trials) and "Adalimumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Tyler Research Institute, LLC" are 33 trials for "All" genders.

Currently, there are NaN active trials in "Tyler Research Institute, LLC". undefined are not yet recruiting, 11 are recruiting, 8 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 12 completed trials in Tyler Research Institute, LLC, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Tyler Research Institute, LLC, 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".